#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Proteus syndrome Palmar-plantar erythrodysaesthesia syndrome Chemical burn Barth syndrome Alexander disease Central nervous system lymphoma Hereditary ataxia Glomerulonephritis Neuroblastoma Cluster headache Paroxysmal nocturnal haemoglobinuria VEXAS syndrome Systemic sclerosis pulmonary Mucopolysaccharidosis II Non-small cell lung cancer More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Diagnostics CADASIL – Trials in Disease Andersen-Tawil syndrome – Basic Information Primary biliary cholangitis – Basic Information Angiosarcoma non-metastatic – Life with Disease Piriformis syndrome – Diagnostics Splenic marginal zone lymphoma – Basic Information Bronchopulmonary dysplasia – Treatment Biotinidase deficiency Glycogen storage disease type V – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Milademetan Elacestrant Pyrimethamine XELAFASLATIDE GSKVX000000044501 Capecitabine BENZYDAMINE HYDROCHLORIDE Oxymetazoline Hydrochloride Lib-01 Monohydrate Delafloxacin Octreotide Acetate Rbl027.2 Olanzapine Palbociclib Baricitinib Obeticholic Acid Ondansetron Db-Oto-3 Cendakimab Crisantaspase More therapies…

    Learn about Your Condition

    Binge eating Psychogenic seizure Prostatitis Escherichia coli Labour pain Huntington's disease Neoplasm malignant Hand dermatitis Lymphoedema Adenomyosis Testicular leiomyosarcoma Diabetic ketoacidosis Rectal neoplasm Acute myocardial infarction Eclampsia Chronic disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Urinary tract infection

  • Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ciprofloxacin
    Belgium

  • Comparing pivmecillinam and gentamicin with standard treatments for hospitalized adults with complicated urinary tract infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Pivmecillinam Hydrochloride
    • Ampicillin Sodium
    • Betamethasone Valerate
    Denmark

  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Pivmecillinam Hydrochloride
    • FOSFOMYCIN CALCIUM
    • Cefuroxime Axetil
    Norway Sweden

  • Study on Fecal Microbiota Transfer for Preventing Recurrent Urinary Tract Infections in Premenopausal Women Using Intestifix

    Recruiting

    2 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Intestifix
    • Fosfomycin Trometamol
    • Ascorbic Acid
    Germany

  • Study of Intravenous Fosfomycin, Tazobactam Sodium, and Ertapenem Sodium for Hospitalized Patients with Complicated Urinary Tract Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • FOSFOMYCIN CALCIUM
    • Ertapenem Sodium
    • Piperacillin Sodium
    Italy

  • Study of Aztreonam-Avibactam and Metronidazole for Children with Serious Gram-Negative Bacterial Infections

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Amikacin
    • Avibactam Sodium
    • Aztreonam
    Czechia Greece Hungary Spain
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!